文献速递关节外科

术前患者报告结局与临床特征对全关节置换术90天费用/资源利用及并发症的预测作用

Preoperative Patient-Reported Outcomes and Clinical Characteristics as Predictors of 90-Day Cost/Utilization and Complications.
PubMed 文献 · J Arthroplasty · 2019-01-31

该研究纳入2017年2家高容量医院926例全关节置换术患者,评估术前HOOS/KOOS JR与VR-12对90天并发症、费用及资源利用的预测价值。多变量分析显示基线VR-12躯体成分评分较高对延长住院、转入专业护理机构、费用超过 bundle 第75百分位及90天 bundle 费用超目标价具有保护作用(P<.01),而VR-12心理成分评分及HOOS/KOOS JR无预测作用。

要点

  • 基线VR-12躯体成分评分较低与90天 bundle 费用较高相关。
  • 基线HOOS/KOOS JR评分对资源利用或费用无预测作用。
  • VR-12与HOOS/KOOS JR均不能预测90天再入院或并发症。

核心结论

  • 基线VR-12躯体成分评分低可预测90天 bundle 费用高。
  • 基线HOOS/KOOS JR评分不能预测资源利用或费用。
  • VR-12与HOOS/KOOS JR均不能预测90天再入院或并发症。

研究设计与样本

  • 回顾性查询2017年2家高容量医院的全部全关节置换术病例。
  • 术前通过电子采集平台收集HOOS/KOOS JR与VR-12。
  • 对纳入Medicare bundle的患者从理赔数据中提取费用数据。
  • 进行双变量与多变量回归分析。
  • 2017年共2108例接受全关节置换术,1182例(56%)因缺失患者报告结局数据被排除,最终研究人群926例,其中199例(21%)有可用费用数据。

主要发现

  • 高 bundle 费用患者更年长、合并血管疾病与贫血、Charlson评分更高(P均<.05)。
  • 高 bundle 费用患者基线VR-12躯体成分评分更低(24 vs 30,P≤.001)。
  • 高 bundle 费用患者延长住院、转入专业护理机构、90天并发症及90天再入院率更高(P均≤.04)。
  • 多变量分析中,基线VR-12躯体成分评分较高对延长住院、转入专业护理机构、费用超过第75百分位及90天 bundle 费用超目标价具有保护作用(P均<.01)。
  • 基线VR-12心理成分评分与HOOS/KOOS JR不能预测并发症或 bundle 费用。

关键数值与推荐

  • 高 bundle 费用患者基线VR-12躯体成分评分为24,非高费用患者为30(P≤.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 2108例中1182例(56%)因缺失患者报告结局数据被排除。
  • 926例中仅199例(21%)有可用费用数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the advent of mandatory bundle payments for total joint arthroplasty (TJA), assessing patients' risk for increased 90-day complications and resource utilization is crucial. This study assesses the degree to which preoperative patient-reported outcomes predict 90-day complications, episode costs, and utilization in TJA patients. METHODS: All TJA cases in 2017 at 2 high-volume hospitals were queried. Preoperative HOOS/KOOS JR (Hip Injury and Osteoarthritis Outcome Score/Knee Injury and Osteoarthritis Outcome Score) and Veterans RAND 12-item health survey (VR-12) were administered to patients preoperatively via e-collection platform. For patients enrolled in the Medicare bundle, cost data were extracted from claims. Bivariate and multivariate regression analyses were performed. RESULTS: In total, 2108 patients underwent TJA in 2017; 1182 (56%) were missing patient-reported outcome data and were excluded. The final study population included 926 patients, 199 (21%) of which had available cost data. Patients with high bundle costs tended to be older, suffer from vascular disease and anemia, and have higher Charlson scores (P < .05 for all). These patients also had lower baseline VR-12 Physical Component Summary Score (PCS; 24 vs 30, P ≤ .001) and higher rates of extended length of stay, skilled nursing facility discharge, 90-day complications, and 90-day readmission (P ≤ .04 for all). In multivariate analysis, higher baseline VR-12 PCS was protective against extended length of stay, skilled nursing facility discharge, >75th percentile bundle cost, and 90-day bundle cost exceeding target bundle price (P < .01 for all). Baseline VR-12 Mental Component Summary Score and HOOS/KOOS JR were not predictive of complications or bundle cost. CONCLUSION: Low baseline VR-12 PCS is predictive of high 90-day bundle costs. Baseline HOOS/KOOS JR scores were not predictive of utilization or cost. Neither VR-12 nor HOOS/KOOS JR was predictive of 90-day readmission or complications.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Snyder DJ, Bienstock DM, Keswani A, et al. Preoperative Patient-Reported Outcomes and Clinical Characteristics as Predictors of 90-Day Cost/Utilization and Complications. J Arthroplasty. 2019. PMID: 30814027. doi:10.1016/j.arth.2019.01.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。